Governance IXICO plc

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:26 2025-12-05 EST			5-day change	1st Jan Change
10.75 ^GBX	0.00%		-2.27%	-8.51%

12-01	IXICO plc Announces Scientific Advisory Board Appointments, Effective December 1, 2025	CI
11-17	Ixico wins GBP3.7 million deal to support Huntington's Disease trial	AN

Executive Committee: IXICO plc

Manager

Positions heldSince

Bram Goorden

52 year

Chief Executive Officer

2024-08-18

Grant Nash

49 year

Chief Operating Officer	2019-08-20
Director of Finance/CFO	2019-08-20
Corporate Secretary	2019-05-30

Robin Wolz

Chief Tech/Sci/R&D Officer

2020-12-31

Composition of the Board of Directors: IXICO plc

Director

CommitteesSince

Mark Warne

50 year

Chairman
Independent Dir/Board Member	2016-09-15

Dipti Amin

61 year

Compensation Committee
Audit Committee	2023-10-04
Compensation Committee Chair	2023-10-04

Katherine Rogers

59 year

Compensation Committee
Audit Committee Chair	2022-04-29

Bram Goorden

52 year

Director/Board Member

2024-08-18

Grant Nash

49 year

Director/Board Member

2019-08-20

Latest Appointments: IXICO plc

12-01	IXICO plc Announces Scientific Advisory Board Appointments, Effective December 1, 2025	CI
04-16	EARNINGS AND TRADING: HEIT changes tack and backs Foresight cash bid	AN
12-10	EARNINGS AND TRADING: Dianomi trading in line; Solid State profit dips	AN
24-08-05	Ixico names Bram Goorden as next chief executive officer	AN
24-08-05	Ixico Hires New CEO	MT
24-08-05	IXICO plc Appoints Bram Goorden as Chief Executive Officer, Effective 19 August 2024	CI
24-01-12	Ixico CEO Cerroni to retire by end of 2024; starts succession search	AN

More news

Former Officers and Directors: IXICO plc

Insider

Positions held

SinceUntil

Giulio Cerroni

Director/Board Member	2017-02-05	2024-08-15
Chief Executive Officer	2017-02-05	2024-08-18

Charles Spicer

Director/Board Member	2013-10-13	2016-09-15
Chairman	2016-09-15	2023-12-31
Corporate Officer/Principal	2013-10-13	2016-01-28

John Bradshaw

Director/Board Member	2013-10-13	2022-04-29
Independent Dir/Board Member	2013-10-13	2022-04-29

Lammert Albers

Corporate Officer/Principal

2019-10-27

2021-12-31

John Hall

Corporate Officer/Principal

2013-10-14

2020-02-29

Conor Wolfson

Comptroller/Controller/Auditor	-	2019-05-30
Director of Finance/CFO	2018-12-10	2019-04-28

Susan Lowther

Director/Board Member	2014-09-30	2018-12-10
Director of Finance/CFO	2014-09-30	2018-12-10
Corporate Secretary	-	2018-12-10

Derek Lionel Glendon Hill

Director/Board Member	2013-10-14	2018-01-21
Chief Executive Officer	1995-11-27	2017-02-05
Founder	1995-11-27	2018-01-21
Corporate Officer/Principal	2017-05-21	2018-01-21

Kate McLeish

Chief Tech/Sci/R&D Officer

2004-12-31

2017-06-30

Janet Munro

Corporate Officer/Principal

2015-11-30

2017-05-31

David Brister

Director/Board Member	2015-11-30	2016-09-15
Independent Dir/Board Member	2015-11-30	-

Andrew Richards

Chairman	2008-12-31	2016-09-15
Independent Dir/Board Member	2008-12-31	2016-09-15

Kenneth M. Tubman

Corporate Officer/Principal

2015-11-30

Krish Ramakrisnan

Sales & Marketing

2014-03-30

Jane Whitrow

Chief Operating Officer	2013-10-14	-
Investor Relations Contact	2013-10-14	-
Corporate Secretary	2013-10-14	-

Timothy Sharpington

Director/Board Member	2013-10-14	-
Independent Dir/Board Member	2013-10-14	-

Michelle Lax

Chief Tech/Sci/R&D Officer

2011-12-31

Maina Bhaman

Director/Board Member

2009-12-31

Romina Oxborough

Chief Operating Officer

Age distribution of managers

Parity Men Women

Male	6
Female	1

Of which Executive Committee

Male	3
Female	0

Of which Directors

Male	4
Female	1

IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.

Employees

Sector

Biotechnology & Medical Research

Calendar

12-08 - Q4 2025 Earnings Release

More about the company